TP53 and breast carcinoma: In addition, the Lys386Asn amino acid variation of cellular tumor antigen p53 protein (UniProtKB/Swiss-Prot ID, P04637) removes the K386 sumoylation site and result in breast cancer (DOID:1612), which is a common malignancy originating from breast epithelial tissue.